Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma

Semmelweis Egyetem, Budapest

Országos Onkológiai Intézet, Budapest

Inselspital Universitätsspital Bern, Bern

Pécsi Tudományegyetem Klinikai Központ, Pécs

Universitair Ziekenhuis Gent, Ghent

Centre Hospitalier de La Rochelle, La Rochelle

Hospital Universitari Arnau de Vilanova, Lleida

Hospital General Universitario Gregorio Marañón, Madrid

Hospital Universitario Fundación Jiménez Díaz, Madrid

Hospital Universitario La Paz, Madrid

Hospital Universitario Quirónsalud Madrid, Pozuelo de Alarcón

Hollings Cancer Center, Charleston

Hôpital Bretonneau, Tours

Hospital Universitario Virgen del Rocío, Seville

Azienda Ospedaliero - Universitaria Careggi, Florence

The Chaim Sheba Medical Center, Tel Aviv

Centre Hospitalier de Dunkerque, Dunkirk

Centre de Lutte Contre le Cancer - Centre Henri-Becquerel, Rouen

Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas

Comprehensive Cancer Centers of Nevada, Las Vegas

Carmel Medical Center, Haifa

Rabin Medical Center - Beilinson Hospital, Petah Tikva

Tel Aviv Sourasky Medical Center, Tel Aviv

Soroka Medical Center, Beersheba

Summit Medical Group - Florham Park Campus, Florham Park

Summit Medical Group, Florham Park

Centre Hospitalier Universitaire Universite Catholique de Louvain, Yvoir

Szpitale Pomorskie Spółka Z Ograniczoną Odpowiedzialnością, Gdynia

Pratia Onkologia Katowice, Katowice

Pratia Poznań, Skorzewo

Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), L'Hospitalet de Llobregat

Hospital Universitario Ramón y Cajal, Madrid

NHS Greater Glasgow and Clyde, Glasgow

Account University College London Hospitals NHS Foundation Trust, London